title: Detection of urinary markers for thiazide diuretics after oral administration of hydrochlorothiazide and altizide-relevance to doping control analysis.
abstract: In sports, thiazide diuretics are used to flush out previously taken prohibited substances with forced diuresis and in sports where weight classes are involved to achieve acute weight loss. Thiazide diuretics include compounds which are very unstable and hydrolyse in aqueous media. Because information regarding the urinary detection of the hydrolysis products is limited, urinary excretion profiles for the hydrolysis product 4-amino-6-chloro-1,3-benzenedisulphonamide were established in 6 healthy volunteers after oral administration of altizide (15 mg per tablet) and hydrochlorothiazide (25mg per tablet). Additionally, the excretion profile of chlorothiazide, a metabolite of altizide and hydrochlorothiazide, was also determined. A quantitative liquid-chromatographic tandem mass spectrometric method to detect the 4 substances was developed and validated. The result of this work shows that altizide is eliminated within 48 h in urine whereas hydrochlorothiazide was detectable after 120 h. Chlorothiazide was determined to be a minor metabolite of altizide and hydrochlorothiazide and could be detected up to 120 h. The hydrolysis product, 4-amino-6-chloro-1,3-benzenedisulphonamide, was detectable 120 h after administration, with concentrations at least 10 times higher than the parent drug. Concentrations ranged between 41-239 and 60-287 ng/mL after altizide and hydrochlorothiazide administration, respectively. The study shows that 4-amino-6-chloro-1,3-benzenedisulphonamide is an important target compound for the long time detection of thiazide diuretics in urine.
authors.affiliation: Department of Clinical Chemistry, DoCoLab, UGent, Zwijnaarde, Belgium. Koen.Deventer@UGent.be
authors.forename: K
authors.initials: K
authors.lastname: Deventer
authors.forename: O J
authors.initials: OJ
authors.lastname: Pozo
authors.forename: P
authors.initials: P
authors.lastname: Van Eenoo
authors.forename: F T
authors.initials: FT
authors.lastname: Delbeke
mesh_terms: D000284:Administration, Oral; D000328:Adult; D001581:Benzothiadiazines / Q000008:administration & dosage / Q000378:metabolism*; D054316:Biomarkers, Pharmacological / Q000652:urine*; D002740:Chlorothiazide / Q000652:urine; D002853:Chromatography, Liquid / Q000379:methods; D004232:Diuretics / Q000008:administration & dosage / Q000378:metabolism; D004300:Doping in Sports; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000008:administration & dosage / Q000378:metabolism*; D016018:Least-Squares Analysis; D016014:Linear Models; D008297:Male; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage / Q000378:metabolism; D013424:Sulfanilamides / Q000652:urine; D053719:Tandem Mass Spectrometry / Q000379:methods
chemical_list: D001581:Benzothiadiazines; D054316:Biomarkers, Pharmacological; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D013424:Sulfanilamides; D006852:Hydrochlorothiazide; C054586:4-amino-6-chloro-1,3-benzenedisulfonamide; D002740:Chlorothiazide; C006480:althiazide